The BIGGEST secret Big Pharma doesn't want you to know about prescription drugs

Unlock the cutting-edge science of longevity. In this video, we take a high-level look at seven prescription drugs and drug classes being studied for their potential to extend healthspan and lifespan. From metformin and rapamycin to SGLT2 inhibitors and PCSK9 inhibitors, we break down mechanisms, human evidence, and why these drugs may influence the biology of aging.
You’ll learn:
How metabolic drugs like metformin and acarbose impact insulin, glucose, and autophagy.
Why rapamycin is considered the strongest anti-aging candidate in animal studies.
How PDE5 and PDE9 inhibitors may support vascular and neurological health.
The overlooked benefits of SGLT2 inhibitors for real-world healthspan extension.
Where the field is headed with senolytics, stem cell preservation, and epigenetic reprogramming.
This isn’t about speculation—it’s about the pathways, trials, and real evidence shaping the future of aging medicine.
If you want deep dives into any of these interventions, drop a comment below!
🔔 Don’t forget to like, subscribe, and turn on notifications for more science-backed insights on longevity and healthspan.